Metabolic profiling of the diabetic heart: Toward a richer picture

Frontiers in Physiology

Volumn 10, Issue MAY, 2019, Pages

  Sowton, Alice P ^a   Griffin, Julian L ^a   Murray, Andrew J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Animal models; Diabetic cardiomyopathy; Heart failure; Lipidomics; Metabolomics; Mitochondria

Indexed keywords

BIOLOGICAL MARKER; KETONE; PHOSPHATE; TRIACYLGLYCEROL;

AMINO ACID METABOLISM; CARDIAC MUSCLE; CHROMATOGRAPHY; DIABETIC CARDIOMYOPATHY; DISEASE COURSE; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLYCOLYSIS; HEART MUSCLE METABOLISM; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPIDOMICS; LIPOTOXICITY; MASS SPECTROMETRY; METABOLIC FINGERPRINTING; METABOLIC SYNDROME X; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PROTEIN BLOOD LEVEL; REVIEW;

EID: 85068261529     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2019.00639     Document Type: Review

References (151)

1. Abdesselam, I., Pepino, P., Troalen, T., Macia, M., Ancel, P., Masi, B., et al. (2015). Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 17:95. doi: 10.1186/s12968-015-0198-x
2. Abdurrachim, D., Ciapaite, J., Wessels, B., Nabben, M., Luiken, J. J., Nicolay, K., et al. (2014). Cardiac diastolic dysfunction in high-fat diet fed mice is associated with lipotoxicity without impairment of cardiac energetics in vivo. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1841, 1525-1537. doi: 10.1016/j.bbalip.2014.07.016
3. Abdurrachim, D., Nabben, M., Hoerr, V., Kuhlmann, M. T., Bovenkamp, P., Ciapaite, J., et al. (2017). Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations. Cardiovasc. Res. 113, 1148-1160. doi: 10.1093/cvr/cvx100
4. Addie, R. D., Balluff, B., Bovée, J. V., Morreau, H., and McDonnell, L. A. (2015). Current state and future challenges of mass spectrometry imaging for clinical research. Anal. Chem. 87, 6426-6433. doi: 10.1021/acs.analchem.5b00416
5. Airhart, S., Cade, W. T., Jiang, H., Coggan, A. R., Racette, S. B., Korenblat, K., et al. (2016). A diet rich in medium-chain fatty acids improves systolic function and alters the lipidomic profile in patients with type 2 diabetes: a pilot study. J. Clin. Endocrinol. Metab. 101, 504-512. doi: 10.1210/jc.2015-3292
6. Ashmore, T., Fernandez, B. O., Branco-Price, C., West, J. A., Cowburn, A. S., Heather, L. C., et al. (2014). Dietary nitrate increases arginine availability and protects mitochondrial complex I and energetics in the hypoxic rat heart. J. Physiol. 592, 4715-4731. doi: 10.1113/jphysiol.2014.275263
7. Atherton, H. J., Schroeder, M. A., Dodd, M. S., Heather, L. C., Carter, E. E., Cochlin, L. E., et al. (2011). Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS. NMR Biomed. 24, 201-208. doi: 10.1002/nbm.1573
8. Aubert, G., Martin, O. J., Horton, J. L., Lai, L., Vega, R. B., Leone, T. C., et al. (2016). The failing heart relies on ketone bodies as a fuel. Circulation 133, 698-705. doi: 10.1161/CIRCULATIONAHA.115.017355
9. Avogaro, A., Nosadini, R., Doria, A., Fioretto, P., Velussi, M., Vigorito, C., et al. (1990). Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am. J. Physiol. Endocrinol. Metab. 258, E606-E618. doi: 10.1152/ajpendo.1990.258.4.E606
10. Baranowski, M., Blachnio-Zabielska, A., Hirnle, T., Harasiuk, D., Matlak, K., Knapp, M., et al. (2010). Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide. J. Lipid Res. 51, 74-80. doi: 10.1194/jlr.M900002-JLR200
11. Basu, R., Oudit, G. Y., Wang, X., Zhang, L., Ussher, J. R., Lopaschuk, G. D., et al. (2009). Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am. J. Physiol. Heart Circ. Physiol. 297, H2096-H2108. doi: 10.1152/ajpheart.00452.2009
12. Bedi, K. C. Jr., Snyder, N. W., Brandimarto, J., Aziz, M., Mesaros, C., Worth, A. J., et al. (2016). Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation 133, 706-716. doi: 10.1161/CIRCULATIONAHA.115.017545
13. Bell, D. S. H. (2003). Diabetic cardiomyopathy. Diabetes Care 26, 2949-2951. doi: 10.2337/diacare.26.10.2949
14. Bilet, L., van de Weijer, T., Hesselink, M. K., Glatz, J. F., Lamb, H. J., Wildberger, J., et al. (2011). Exercise-induced modulation of cardiac lipid content in healthy lean young men. Basic Res. Cardiol. 106, 307-315. doi: 10.1007/s00395-010-0144-x
15. Bing, R. J., Siegel, A., Ungar, I., and Gilbert, M. (1954). Metabolism of the human heart: II. Studies on fat, ketone and amino acid metabolism. Am. J. Med. 16, 504-515. doi: 10.1016/0002-9343(54)90365-4
16. Bloomgarden, Z. (2018). Diabetes and branched-chain amino acids: what is the link? J. Diabetes 10, 350-352. doi: 10.1111/1753-0407.12645
17. Boardman, N. T., Hafstad, A. D., Lund, J., Rossvoll, L., and Aasum, E. (2017). Exercise of obese mice induces cardioprotection and oxygen sparing in hearts exposed to high-fat load. Am. J. Physiol. Heart Circ. Physiol. 313, H1054-H1062. doi: 10.1152/ajpheart.00382.2017
18. Bollano, E., Omerovic, E., Svensson, H., Waagstein, F., and Fu, M. (2007). Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats. Int. J. Cardiol. 114, 195-201. doi: 10.1016/j.ijcard.2006.01.027
19. Braunwald, E. (1978). “Heart failure: an overview,” in Heart Failure, ed. A. P. Fishman (New York, NY: McGraw Hill), 55-70.
20. Bucci, M., Borra, R., Någren, K., Pärkkä, J. P., Ry, S. D., Maggio, R., et al. (2012). Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans. Cardiovasc. Ther. 30, 333-341. doi: 10.1111/j.1755-5922.2011.00275.x
21. Buettner, R., Schölmerich, J., and Bollheimer, L. C. (2007). High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 15, 798-808. doi: 10.1038/oby.2007.608
22. Bugger, H., and Abel, E. D. (2009). Rodent models of diabetic cardiomyopathy. Dis. Model. Mech. 2, 454-466. doi: 10.1242/dmm.001941
23. Bugger, H., and Abel, E. D. (2010). Mitochondria in the diabetic heart. Cardiovasc. Res. 88, 229-240. doi: 10.1093/cvr/cvq239
24. Chatham, J. C., and Forder, J. R. (1993). A 13C-NMR study of glucose oxidation in the intact functioning rat heart following diabetes-induced cardiomyopathy. J. Mol. Cell. Cardiol. 25, 1203-1213. doi: 10.1006/jmcc.1993.1133
25. Chatham, J. C., and Forder, J. R. (1997). Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 273, H52-H58. doi: 10.1152/ajpheart.1997.273.1.H52
26. Chatham, J. C., Gao, Z.-P., and Forder, J. R. (1999). Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. Am. J. Physiol. Endocrinol. Metab. 277, E342-E351. doi: 10.1152/ajpendo.1999.277.2.E342
27. Chatham, J. C., and Seymour, A.-M. (2002). Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc. Res. 55, 104-112. doi: 10.1016/s0008-6363(02)00399-1
28. Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., et al. (1996). Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491-495. doi: 10.1016/s0092-8674(00)81294-5
29. Chokshi, A., Drosatos, K., Cheema, F. H., Ji, R., Khawaja, T., Yu, S., et al. (2012). Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 125, 2844-2853. doi: 10.1161/CIRCULATIONAHA.111.060889
30. Chong, C.-R., Clarke, K., and Levelt, E. (2017). Metabolic remodelling in diabetic cardiomyopathy. Cardiovasc. Res. 113, 422-430. doi: 10.1093/cvr/cvx018
31. Cole, M. A., Murray, A. J., Cochlin, L. E., Heather, L. C., McAleese, S., Knight, N. S., et al. (2011). A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res. Cardiol. 106, 447-457. doi: 10.1007/s00395-011-0156-1
32. Coort, S. L. M., Hasselbaink, D. M., Koonen, D. P. Y., Willems, J., Coumans, W. A., Chabowski, A., et al. (2004). Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes 53, 1655-1663. doi: 10.2337/diabetes.53.7.1655
33. Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., and Garg, R. (2005). Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454. doi: 10.1161/01.CIR.0000158483.13093.9D
34. Davis, S. N. (2004). The role of glimepiride in the effective management of Type 2 diabetes. J. Diabetes Complicat. 18, 367-376. doi: 10.1016/j.jdiacomp.2004.07.001
35. Deeds, M., Anderson, J., Armstrong, A., Gastineau, D., Hiddinga, H., Jahangir, A., et al. (2011). Single dose streptozotocin induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 45, 131-140. doi: 10.1258/la.2010.010090
36. Denton, R. M., and Randle, P. J. (1967). Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscles. Effects of alloxan-diabetes and perfusion. Biochem. J. 104, 416-422. doi: 10.1042/bj1040416
37. Derome, A. E. (1987). Modern NMR Techniques for Chemistry Research. Oxford: Pergamon Press.
38. Diakos, N. A., Navankasattusas, S., Abel, E. D., Rutter, J., McCreath, L., Ferrin, P., et al. (2016). Evidence of glycolysis up-regulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning. JACC Basic Transl. Sci. 1, 432-444. doi: 10.1016/j.jacbts.2016.06.009
39. Diamant, M., Lamb, H. J., Groeneveld, Y., Endert, E. L., Smit, J. W. A., Bax, J. J., et al. (2003). Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J. Am. Coll. Cardiol. 42, 328-335. doi: 10.1016/s0735-1097(03)00625-9
40. Dodd, M. S., Sousa Fialho, M., da, L., Montes Aparicio, C. N., Kerr, M., Timm, K. N., et al. (2018). Fatty acids prevent hypoxia-inducible factor-1α signaling through decreased succinate in diabetes. JACC Basic Transl. Sci. 3, 485-498. doi: 10.1016/j.jacbts.2018.04.005
41. Dong, S., Zhang, R., Liang, Y., Shi, J., Li, J., Shang, F., et al. (2017). Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis. Diabetol. Metab. Syndr. 9:56. doi: 10.1186/s13098-017-0249-6
42. Dong, S., Zhang, S., Chen, Z., Zhang, R., Tian, L., Cheng, L., et al. (2018). Berberine could ameliorate cardiac dysfunction via interfering myocardial lipidomic profiles in the rat model of diabetic cardiomyopathy. Front. Physiol. 9:1042. doi: 10.3389/fphys.2018.01042
43. Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., and Griffin, J. L. (2011). Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 40, 387-426. doi: 10.1039/B906712B
44. Ernande, L., and Derumeaux, G. (2012). Diabetic cardiomyopathy: myth or reality? Arch. Cardiovasc. Dis. 105, 218-225. doi: 10.1016/j.acvd.2011.11.007
45. Ferrannini, E., Baldi, S., Frascerra, S., Astiarraga, B., Heise, T., Bizzotto, R., et al. (2016). Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes. Diabetes 65, 1190-1195. doi: 10.2337/db15-1356
46. Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., et al. (2003). A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad. Sci. U.S.A. 100, 1226-1231. doi: 10.1073/pnas.0336724100
47. Friedman, J. M., Leibel, R. L., Siegel, D. S., Walsh, J., and Bahary, N. (1991). Molecular mapping of the mouse ob mutation. Genomics 11, 1054-1062. doi: 10.1016/0888-7543(91)90032-A
48. Girard, C. A., Wunderlich, F. T., Shimomura, K., Collins, S., Kaizik, S., Proks, P., et al. (2009). Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic β cells recapitulates neonatal diabetes. J. Clin. Invest. 119, 80-90. doi: 10.1172/JCI35772
49. Golman, K., Petersson, J. S., Magnusson, P., Johansson, E., Åkeson, P., Chai, C.-M., et al. (2008). Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn. Reson. Med. 59, 1005-1013. doi: 10.1002/mrm.21460
50. Griffin, J. L., Atherton, H., Shockcor, J., and Atzori, L. (2011). Metabolomics as a tool for cardiac research. Nat. Rev. Cardiol. 8, 630-643. doi: 10.1038/nrcardio.2011.138
51. Hall, Z., Bond, N. J., Ashmore, T., Sanders, F., Ament, Z., Wang, X., et al. (2017). Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hepatology 65, 1165-1180. doi: 10.1002/hep.28953
52. Hammer, S., van der Meer, R. W., Lamb, H. J., de Boer, H. H., Bax, J. J., de Roos, A., et al. (2008a). Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 295, E714-E718. doi: 10.1152/ajpendo.90413.2008
53. Hammer, S., van der Meer, R. W., Lamb, H. J., Schär, M., de Roos, A., Smit, J. W. A., et al. (2008b). Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J. Clin. Endocrinol. Metab. 93, 497-503. doi: 10.1210/jc.2007-2015
54. Han, X., Yang, J., Cheng, H., Yang, K., Abendschein, D. R., and Gross, R. W. (2005). Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 44, 16684-16694. doi: 10.1021/bi051908a
55. Han, X., Yang, J., Yang, K., Zhao, Z., Abendschein, D. R., and Gross, R. W. (2007). Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes:? a shotgun lipidomics study. Biochemistry 46, 6417-6428. doi: 10.1021/bi7004015
56. Herrero, P., Peterson, L. R., McGill, J. B., Matthew, S., Lesniak, D., Dence, C., et al. (2006). Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J. Am. Coll. Cardiol. 47, 598-604. doi: 10.1016/j.jacc.2005.09.030
57. Herrmann, G., and Decherd, G. M. Jr. (1939). The chemical nature of heart failure. Ann. Intern. Med. 12, 1233-1244. doi: 10.7326/0003-4819-12-8-1233
58. Holloway, C. J., Cochlin, L. E., Emmanuel, Y., Murray, A., Codreanu, I., Edwards, L. M., et al. (2011). A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects. Am. J. Clin. Nutr. 93, 748-755. doi: 10.3945/ajcn.110.002758
59. Hölscher, M. E., Bode, C., and Bugger, H. (2016). Diabetic cardiomyopathy: does the type of diabetes matter? Int. J. Mol. Sci. 17:2136. doi: 10.3390/ijms17122136
60. How, O.-J., Aasum, E., Severson, D. L., Chan, W. Y. A., Essop, M. F., and Larsen, T. S. (2006). Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55, 466-473. doi: 10.2337/diabetes.55.02.06.db05-1164
61. Hummel, K. P., Dickie, M. M., and Coleman, D. L. (1966). Diabetes, a new mutation in the mouse. Science 153, 1127-1128. doi: 10.1126/science.153.3740.1127
62. Ilaiwy, A., Liu, M., Parry, T. L., Bain, J. R., Newgard, C. B., Schisler, J. C., et al. (2016). Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo. Metabolomics 12:95. doi: 10.1007/s11306-016-1022-9
63. Jain, S. K., and Levine, S. N. (1995). Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats. Free Radic. Biol. Med. 18, 337-341. doi: 10.1016/0891-5849(94)00114-Y
64. Jankovic, D., Winhofer, Y., Promintzer-Schifferl, M., Wohlschläger-Krenn, E., Anderwald, C. H., Wolf, P., et al. (2012). Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus. PLoS One 7:e50077. doi: 10.1371/journal.pone.0050077
65. Jeffrey, F. M., Diczku, V., Sherry, A. D., and Malloy, C. R. (1995). Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration. Basic Res. Cardiol. 90, 388-396. doi: 10.1007/BF00788500
66. Jia, G., Hill, M. A., and Sowers, J. R. (2018). Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ. Res. 122, 624-638. doi: 10.1161/CIRCRESAHA.117.311586
67. Kaimoto, S., Hoshino, A., Ariyoshi, M., Okawa, Y., Tateishi, S., Ono, K., et al. (2017). Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure. Am. J. Physiol. Heart Circ. Physiol. 312, H305-H313. doi: 10.1152/ajpheart.00553.2016
68. Kankaanpää, M., Lehto, H.-R., Pärkkä, J. P., Komu, M., Viljanen, A., Ferrannini, E., et al. (2006). Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J. Clin. Endocrinol. Metab. 91, 4689-4695. doi: 10.1210/jc.2006-0584
69. Kler, R. S., Jackson, S., Bartlett, K., Bindoff, L. A., Eaton, S., Pourfarzam, M., et al. (1991). Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J. Biol. Chem. 266, 22932-22938.
70. Kuo, T. H., Moore, K. H., Giacomelli, F., and Wiener, J. (1983). Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. Diabetes 32, 781-787. doi: 10.2337/diab.32.9.781
71. Kuwahara, Y., Yanagishita, T., Konno, N., and Katagiri, T. (1997). Changes in microsomal membrane phospholipids and fatty acids and in activities of membrane-bound enzyme in diabetic rat heart. Basic Res. Cardiol. 92, 214-222. doi: 10.1007/BF00788516
72. Lanza, I. R., and Nair, K. S. (2009). Functional assessment of isolated mitochondria in vitro. Methods Enzymol. 457, 349-372. doi: 10.1016/S0076-6879(09)05020-4
73. Larsen, T. S., and Aasum, E. (2008). Metabolic (In)flexibility of the diabetic heart. Cardiovasc. Drugs Ther. 22, 91-95. doi: 10.1007/s10557-008-6083-1
74. Le Page, L. M., Rider, O. J., Lewis, A. J., Ball, V., Clarke, K., Johansson, E., et al. (2015). Increasing pyruvate dehydrogenase flux as a treatment for diabetic cardiomyopathy: a combined 13C hyperpolarized magnetic resonance and echocardiography study. Diabetes 64, 2735-2743. doi: 10.2337/db14-1560
75. Lehnen, A. M., Rodrigues, B., Irigoyen, M. C., De Angelis, K., and Schaan, B. D. (2013). Cardiovascular changes in animal models of metabolic syndrome. J. Diabetes Res. 2013:761314. doi: 10.1155/2013/761314
76. Lenzen, S. (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51, 216-226. doi: 10.1007/s00125-007-0886-7
77. Levelt, E., Mahmod, M., Piechnik, S. K., Ariga, R., Francis, J. M., Rodgers, C. T., et al. (2016a). Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes. Diabetes 65, 44-52. doi: 10.2337/db15-0627
78. Levelt, E., Rodgers, C. T., Clarke, W. T., Mahmod, M., Ariga, R., Francis, J. M., et al. (2016b). Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur. Heart J. 37, 3461-3469. doi: 10.1093/eurheartj/ehv442
79. Lewin, T. M., de Jong, H., Schwerbrock, N. J. M., Hammond, L. E., Watkins, S. M., Combs, T. P., et al. (2008). Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1781, 352-358. doi: 10.1016/j.bbalip.2008.05.001
80. Liang, Z., Leo, S., Wen, H., Ouyang, M., Jiang, W., and Yang, K. (2015). Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats. BMC Cardiovasc. Disord. 15:42. doi: 10.1186/s12872-015-0030-4
81. Lutz, T. A., and Woods, S. C. (2012). Overview of animal models of obesity. Curr. Protoc. Pharmacol. 58, 5.61.1-5.61.18. doi: 10.1002/0471141755.ph0561s58
82. Mansor, L. S., Gonzalez, E. R., Cole, M. A., Tyler, D. J., Beeson, J. H., Clarke, K., et al. (2013). Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin. Cardiovasc. Diabetol. 12:136. doi: 10.1186/1475-2840-12-136
83. Matsui, H., Okumura, K., Mukawa, H., Hibino, M., Toki, Y., and Ito, T. (1997). Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy. Can. J. Cardiol. 13, 373-379.
84. McGavock, J. M., Lingvay, I., Zib, I., Tillery, T., Salas, N., Unger, R., et al. (2007). Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116, 1170-1175. doi: 10.1161/CIRCULATIONAHA.106.645614
85. Menger, R. F., Stutts, W. L., Anbukumar, D. S., Bowden, J. A., Ford, D. A., and Yost, R. A. (2012). MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model. Anal. Chem. 84, 1117-1125. doi: 10.1021/ac202779h
86. Miloushev, V. Z., Keshari, K. R., and Holodny, A. I. (2016). Hyperpolarization MRI. Top. Magn. Reson. Imaging 25, 31-37. doi: 10.1097/RMR.0000000000000076
87. Monti, L. D., Landoni, C., Setola, E., Galluccio, E., Lucotti, P., Sandoli, E. P., et al. (2004). Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in type 2 diabetic patients. Am. J. Physiol. Heart Circ. Physiol. 287, H1225-H1231. doi: 10.1152/ajpheart.00629.2003
88. NCD Risk Factor Collaboration (NCD-RisC) (2016). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 44 million participants. Lancet 387, 1513-1530. doi: 10.1016/s0140-6736(16)00618-8
89. Neubauer, S. (2007). The failing heart - an engine out of fuel. N. Engl. J. Med. 356, 1140-1151. doi: 10.1056/NEJMra063052
90. Neubauer, S., Horn, M., Cramer, M., Harre, K., Newell, J. B., Peters, W., et al. (1997). Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96, 2190-2196. doi: 10.1161/01.CIR.96.7.2190
91. Ng, A. C. T., Delgado, V., Bertini, M., van der Meer, R. W., Rijzewijk, L. J., Hooi Ewe, S., et al. (2010). Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation 122, 2538-2544. doi: 10.1161/CIRCULATIONAHA.110.955542
92. Nyman, K., Granér, M., Pentikäinen, M. O., Lundbom, J., Hakkarainen, A., Sirén, R., et al. (2013). Cardiac steatosis and left ventricular function in men with metabolic syndrome. J. Cardiovasc. Magn. Reson. 15:103. doi: 10.1186/1532-429X-15-103
93. O'Brien, K. A., Griffin, J. L., Murray, A. J., and Edwards, L. M. (2015). Mitochondrial responses to extreme environments: insights from metabolomics. Extrem Physiol. Med. 4:7. doi: 10.1186/s13728-015-0026-9
94. O'Donnell, J. M., Zampino, M., Alpert, N. M., Fasano, M. J., Geenen, D. L., and Lewandowski, E. D. (2006). Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am. J. Physiol. Endocrinol. Metab. 290, E448-E455. doi: 10.1152/ajpendo.00139.2005
95. Palermo, A., Maggi, D., Maurizi, A. R., Pozzilli, P., and Buzzetti, R. (2014). Prevention of type 2 diabetes mellitus: is it feasible? Diabetes Metab. Res. Rev. 30, 4-12. doi: 10.1002/dmrr.2513
96. Pappachan, J. M., Varughese, G. I., Sriraman, R., and Arunagirinathan, G. (2013). Diabetic cardiomyopathy: pathophysiology, diagnostic evaluation and management. World J. Diabetes 4, 177-189. doi: 10.4239/wjd.v4.i5.177
97. Perseghin, G., Ntali, G., Cobelli, F. D., Lattuada, G., Esposito, A., Belloni, E., et al. (2007). Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care 30, 1520-1526. doi: 10.2337/dc06-2429
98. Peterson, L. R., Herrero, P., Schechtman, K. B., Racette, S. B., Waggoner, A. D., Kisrieva-Ware, Z., et al. (2004). Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109, 2191-2196. doi: 10.1161/01.CIR.0000127959.28627.F8
99. Randle, P. J., Garland, P. B., Hales, C. N., and Newsholme, E. A. (1963). The glucose fatty acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281, 785-789. doi: 10.1016/S0140-6736(63)91500-9
100. Rees, D. A., and Alcolado, J. C. (2005). Animal models of diabetes mellitus. Diabet. Med. 22, 359-370. doi: 10.1111/j.1464-5491.2005.01499.x
101. Reid, J. V. O., Lochner, A., and Brink, A. J. (1970). Effect of a high fat diet on the metabolism and mechanical behaviour of the isolated rat heart. J. Mol. Cell. Cardiol. 1, 209-220. doi: 10.1016/0022-2828(70)90002-7
102. Reingold, J. S., McGavock, J. M., Kaka, S., Tillery, T., Victor, R. G., and Szczepaniak, L. S. (2005). Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am. J. Physiol. Endocrinol. Metab. 289, E935-E939. doi: 10.1152/ajpendo.00095.2005
103. Rider, O. J., Francis, J. M., Tyler, D., Byrne, J., Clarke, K., and Neubauer, S. (2013). Effects of weight loss on myocardial energetics and diastolic function in obesity. Int. J. Cardiovasc. Imaging 29, 1043-1050. doi: 10.1007/s10554-012-0174-6
104. Rijzewijk, L. J., van der Meer, R. W., Lamb, H. J., de Jong, H. W. A. M., Lubberink, M., Romijn, J. A., et al. (2009). Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J. Am. Coll. Cardiol. 54, 1524-1532. doi: 10.1016/j.jacc.2009.04.074
105. Rijzewijk, L. J., van der Meer, R. W., Smit, J. W. A., Diamant, M., Bax, J. J., Hammer, S., et al. (2008). Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J. Am. Coll. Cardiol. 52, 1793-1799. doi: 10.1016/j.jacc.2008.07.062
106. Rohm, M., Savic, D., Ball, V., Curtis, M. K., Bonham, S., Fischer, R., et al. (2018). Cardiac dysfunction and metabolic inflexibility in a mouse model of diabetes without dyslipidemia. Diabetes 67, 1057-1067. doi: 10.2337/db17-1195
107. Rosca, M. G., and Hoppel, C. L. (2010). Mitochondria in heart failure. Cardiovasc. Res. 88, 40-50. doi: 10.1093/cvr/cvq240
108. Rossini, A. A., Like, A. A., Chick, W. L., Appel, M. C., and Cahill, G. F. (1977). Studies of streptozotocin-induced insulitis and diabetes. Proc. Natl. Acad. Sci. U.S.A. 74, 2485-2489. doi: 10.1073/pnas.74.6.2485
109. Scheuermann-Freestone, M., Madsen, P. L., Manners, D., Blamire, A. M., Buckingham, R. E., Styles, P., et al. (2003). Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107, 3040-3046. doi: 10.1161/01.CIR.0000072789.89096.10
110. Schnedl, W. J., Ferber, S., Johnson, J. H., and Newgard, C. B. (1994). STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326-1333. doi: 10.2337/diab.43.11.1326
111. Schooneman, M. G., Vaz, F. M., Houten, S. M., and Soeters, M. R. (2013). Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62, 1-8. doi: 10.2337/db12-0466
112. Schroeder, M. A., Atherton, H. J., Ball, D. R., Cole, M. A., Heather, L. C., Griffin, J. L., et al. (2009). Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. FASEB J. 23, 2529-2538. doi: 10.1096/fj.09-129171
113. Schroeder, M. A., Atherton, H. J., Heather, L. C., Griffin, J. L., Clarke, K., Radda, G. K., et al. (2011). Determining the in vivo regulation of cardiac pyruvate dehydrogenase based on label flux from hyperpolarised [1-13C]pyruvate. NMR Biomed. 24, 980-987. doi: 10.1002/nbm.1668
114. Schroeder, M. A., Cochlin, L. E., Heather, L. C., Clarke, K., Radda, G. K., and Tyler, D. J. (2008). In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc. Natl. Acad. Sci. U.S.A. 105, 12051-12056. doi: 10.1073/pnas.0805953105
115. Serreze, D. V., and Leiter, E. H. (1994). Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6, 900-906. doi: 10.1016/0952-7915(94)90011-6
116. Seymour, A.-M. L., Giles, L., Ball, V., Miller, J. J., Clarke, K., Carr, C. A., et al. (2015). In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy. Cardiovasc. Res. 106, 249-260. doi: 10.1093/cvr/cvv101
117. Shaw Dunn, J., Sheehan, H. L., and Mcletchie, N. G. B. (1943). Necrosis of islets of langerhans produced experimentally. Lancet 241, 484-487. doi: 10.1016/s0140-6736(00)42072-6
118. Shiota, M., and Printz, R. L. (2012). “Diabetes in zucker diabetic fatty rat,” in Animal Models in Diabetes Research Methods in Molecular Biology, eds H.-G. Joost, H. Al-Hasani, and A. Schürmann (Totowa, NJ: Humana Press), 103-123. doi: 10.1007/978-1-62703-068-7_8
119. Shoghi, K. I., Gropler, R. J., Sharp, T., Herrero, P., Fettig, N., Su, Y., et al. (2008). Time course of alterations in myocardial glucose utilization in the zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation. J. Nucl. Med. 49, 1320-1327. doi: 10.2967/jnumed.108.051672
120. Spindler, M., Saupe, K. W., Tian, R., Ahmed, S., Matlib, M. A., and Ingwall, J. S. (1999). Altered creatine kinase enzyme kinetics in diabetic cardiomyopathy. A 31P NMR magnetization transfer study of the intact beating rat heart. J. Mol. Cell. Cardiol. 31, 2175-2189. doi: 10.1006/jmcc.1999.1044
121. Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. L., and Ramarao, P. (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52, 313-320. doi: 10.1016/j.phrs.2005.05.004
122. Stanley, W. C., Recchia, F. A., and Lopaschuk, G. D. (2005). Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093-1129. doi: 10.1152/physrev.00006.2004
123. Su, X., Han, X., Mancuso, D. J., Abendschein, D. R., and Gross, R. W. (2005). Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium:? identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics. Biochemistry 44, 5234-5245. doi: 10.1021/bi047773a
124. Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A., and Feinglos, M. N. (1988). Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37, 1163-1167. doi: 10.2337/diab.37.9.1163
125. Swan, J. W., Walton, C., Godsland, I. F., Clark, A. L., Coats, A. J. S., and Oliver, M. F. (1994). Insulin resistance in chronic heart failure. Eur. Heart J. 15, 1528-1532. doi: 10.1093/oxfordjournals.eurheartj.a060425
126. Szczepaniak, L. S., Dobbins, R. L., Metzger, G. J., Sartoni-D'Ambrosia, G., Arbique, D., Vongpatanasin, W., et al. (2003). Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn. Reson. Med. 49, 417-423. doi: 10.1002/mrm.10372
127. Thisted, L., Lindsay, R. T., Fosgerau, K., Secher, T., Thomsen, M. B., Jespersen, T., et al. (2018). Novel “Dual Hit” rat model of diabetic cardiomyopathy. Diabetes 67, 466-P. doi: 10.2337/db18-466-P
128. Towner, R. A., Smith, N., Saunders, D., Carrizales, J., Lupu, F., Silasi-Mansat, R., et al. (2015). In vivo targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice. Free Radic. Res. 49, 1140-1146. doi: 10.3109/10715762.2015.1050587
129. Unger, R., and Orci, L. (2000). Lipotoxic diseases of nonadipose tissues in obesity. Int. J. Obes. 24, S28-S32. doi: 10.1038/sj.ijo.0801498
130. Utz, W., Engeli, S., Haufe, S., Kast, P., Böhnke, J., Haas, V., et al. (2013). Moderate dietary weight loss reduces myocardial steatosis in obese and overweight women. Int. J. Cardiol. 167, 905-909. doi: 10.1016/j.ijcard.2012.03.104
131. van den Brom, C. E., Huisman, M. C., Vlasblom, R., Boontje, N. M., Duijst, S., Lubberink, M., et al. (2009). Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc. Diabetol. 8:39. doi: 10.1186/1475-2840-8-39
132. van der Meer, R. W., Rijzewijk, L. J., de Jong, H. W. A. M., Lamb, H. J., Lubberink, M., Romijn, J. A., et al. (2009). Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 119, 2069-2077. doi: 10.1161/CIRCULATIONAHA.108.803916
133. Vazquez, E. J., Berthiaume, J. M., Kamath, V., Achike, O., Buchanan, E., Montano, M. M., et al. (2015). Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart. Cardiovasc. Res. 107, 453-465. doi: 10.1093/cvr/cvv183
134. Wallimann, T., Tokarska-Schlattner, M., and Schlattner, U. (2011). The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40, 1271-1296. doi: 10.1007/s00726-011-0877-3
135. Wang, B., Chandrasekera, P. C., and Pippin, J. J. (2014). Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr. Diabetes Rev. 10, 131-145. doi: 10.2174/1573399810666140508121012
136. Wang, J., Takeuchi, T., Tanaka, S., Kubo, S.-K., Kayo, T., Lu, D., et al. (1999). A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse. J. Clin. Invest. 103, 27-37. doi: 10.1172/JCI4431
137. Wang, P., Lloyd, S. G., Zeng, H., Bonen, A., and Chatham, J. C. (2005). Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am. J. Physiol. Heart Circ. Physiol. 288, H2102-H2110. doi: 10.1152/ajpheart.00935.2004
138. Wang, X., West, J. A., Murray, A. J., and Griffin, J. L. (2015). Comprehensive metabolic profiling of age-related mitochondrial dysfunction in the high-fat-fed ob/ob mouse heart. J. Proteome Res. 14, 2849-2862. doi: 10.1021/acs.jproteome.5b00128
139. Welch, M. J., Lewis, J. S., Kim, J., Sharp, T. L., Dence, C. S., Gropler, R. J., et al. (2006). Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study. J. Nucl. Med. 47, 689-697.
140. Wicker, L. S., Miller, B. J., Coker, L. Z., McNally, S. E., Scott, S., Mullen, Y., et al. (1987). Genetic control of diabetes and insulitis in the nonobese diabetic (n.d.) mouse. J. Exp. Med. 165, 1639-1654. doi: 10.1084/jem.165.6.1639
141. Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., et al. (2007). HMDB: the human metabolome database. Nucleic Acids Res. 35, D521-D526. doi: 10.1093/nar/gkl923
142. Wong, S. K., Chin, K.-Y., Suhaimi, F. H., Fairus, A., and Ima-Nirwana, S. (2016). Animal models of metabolic syndrome: a review. Nutr. Metab. 13:65.
143. Wu, J., and Yan, L.-J. (2015). Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity. Diabetes Metab. Syndr. Obes. 8, 181-188. doi: 10.2147/DMSO.S82272
144. Yoshioka, M., Kayo, T., Ikeda, T., and Koizuni, A. (1997). A novel locus, Mody4, distal to D7Mit189 o chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46, 887-894. doi: 10.2337/diab.46.5.887
145. Zhabyeyev, P., Gandhi, M., Mori, J., Basu, R., Kassiri, Z., Clanachan, A., et al. (2013). Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload. Cardiovasc. Res. 97, 676-685. doi: 10.1093/cvr/cvs424
146. Zhang, L., Ussher, J. R., Oka, T., Cadete, V. J. J., Wagg, C., and Lopaschuk, G. D. (2011). Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation. Cardiovasc. Res. 89, 148-156. doi: 10.1093/cvr/cvq266
147. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. doi: 10.1038/372425a0
148. Zhao, L., Dong, M., Xu, C., Zheng, H., Wei, T., Liu, K., et al. (2018). Identification of energy metabolism changes in diabetic cardiomyopathy rats using a metabonomic approach. Cell. Physiol. Biochem. 48, 934-946. doi: 10.1159/000491960
149. Zucker, L. M., and Antoniades, H. N. (1972). Insulin and obesity in the zucker genetically obese rat “Fatty.”. Endocrinology 90, 1320-1330. doi: 10.1210/endo-90-5-1320
150. Zucker, L. M., and Zucker, T. F. (1961). Fatty, a new mutation in the rat. J. Hered. 52, 275-278. doi: 10.1093/oxfordjournals.jhered.a107093
151. Zuo, H.-L., Yang, F.-Q., Huang, W.-H., and Xia, Z.-N. (2013). Preparative gas chromatography and its applications. J. Chromatogr. Sci. 51, 704-715. doi: 10.1093/chromsci/bmt040